Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2018-07
-
GCRV Entry and the Limits of Latrunculin B
2026-08-17
Wang et al. used pharmacological inhibitors, transmission electron microscopy, and real-time quantitative PCR to define how genotype III grass carp reovirus enters CIK cells. The study identified a dynamin-dependent, acidification-dependent clathrin pathway and showed that Latrunculin B did not block infection under the tested conditions, an important boundary for interpreting actin-related entry mechanisms.
-
ASCH Proteins and N4-Acetylcytidine Processing
2026-08-16
Meng et al. define how the ASCH-domain protein EcYqfB hydrolyzes free N4-acetylcytidine into cytidine while showing that it does not remove ac4C from RNA. Structural comparisons with mouse EOLA1 and the human TRIP4-ASCH domain separate nucleoside processing from RNA modification turnover and provide a framework for better nucleotide processing enzyme assays.
-
Icatibant in Viral Infections: Evidence and Limits
2026-08-15
This reference letter frames icatibant as a mechanism-guided intervention for severe viral disease in which bradykinin-driven vascular permeability contributes to hypotension, edema, and organ injury. Its key contribution is translational rather than definitive: case observations in Puumala hantavirus infection, together with a cited COVID-19 trial, support early investigation while leaving efficacy in hantavirus disease unproven.
-
2',7'-Dichlorofluorescein diacetate ROS Workflow
2026-08-14
Turn a broadly responsive redox dye into a controlled intracellular ROS measurement workflow for microscopy, flow cytometry, and plate assays. The approach translates findings from a ROS-responsive pancreatic cancer nanocarrier study into practical controls, assay conditions, and interpretation safeguards.
-
DM-β-CD Raises Mianserin HCl Cytotoxicity
2026-08-14
The reference study shows that heptakis (2,6-di-O-methyl)-β-cyclodextrin forms an inclusion complex with mianserin hydrochloride but does not reduce its cellular toxicity. Instead, the methylated cyclodextrin increased toxicity in B14 cell assays, emphasizing that improved drug solubility or complex formation does not necessarily produce a safer formulation.
-
AMPK–p62 Feedback Under Metabolic Stress
2026-08-13
This 2024 study identifies a double-positive feedback loop in which metabolic stress activates both AMPK and SQSTM1/p62, coordinating NRF2-dependent antioxidant defense with energy adaptation. The findings connect lysosomal acidification, TFEB/TFE3 regulation, ROS-dependent TAK1 signaling, and KEAP1 degradation, offering a mechanistic explanation for pathway cooperation in metabolically stressed lung cancer cells.
-
PRMT5, Splicing, and Metabolism in MYCN Neuroblastoma
2026-08-13
This Cancer Letters study defines a mechanistic connection between PRMT5-dependent splicing, epitranscriptomic regulation, and glutamine metabolism in MYCN-amplified neuroblastoma. Its integrated pharmacological, transcriptomic, isotope-tracing, molecular, and mouse-model evidence identifies altered glutaminase regulation as a major component of spliceosomal vulnerability and provides a framework for testing downstream metabolic dependencies.
-
Pollen Interference in EEM Hazard Detection
2026-08-12
A 2024 Molecules study shows that pollen can distort fluorescence-based classification of hazardous bioaerosols, but spectral transformations—especially fast Fourier transform processing—can substantially improve recognition. The work combines excitation–emission matrix spectroscopy with preprocessing and random forest classification to distinguish pollen from bacterial and toxin-related signals.
-
Novel PDK4 Inhibitors for Metabolic Disease
2026-08-12
This 2019 Journal of Medicinal Chemistry study describes an anthraquinone-derived series of allosteric pyruvate dehydrogenase kinase 4 inhibitors, identifying compound 8c as a potent biochemical hit with activity in metabolic, allergic, and cancer-related models. Its combination of structure–activity optimization, metabolic and pharmacokinetic profiling, docking, and mouse efficacy studies provides a useful preclinical framework for developing PDK4-directed therapies.
-
Hexamethonium Bromide in Autonomic Assays
2026-08-11
Learn how Hexamethonium Bromide, SKU B1592, can serve as a mechanistic probe when cholinergic signaling may confound cell viability, proliferation, or cardiovascular experiments. This scenario-based guide covers assay interpretation, protocol planning, solution handling, and evidence-based product selection.
-
PTT and CD47 Blockade in Oral Cancer
2026-08-11
A 2026 study shows that photothermal therapy (PTT) can overcome two major barriers to CD47-based macrophage therapy in oral squamous cell carcinoma: insufficient pro-phagocytic signaling and poor macrophage access to tumor cells. By inducing calreticulin exposure and remodeling the extracellular matrix, PTT substantially improves the antitumor activity of CD47 blockade in vitro and in vivo.
-
CCK-8 in Lipotoxicity: Measuring Mechanism, Not Just Cells
2026-08-10
A mechanistic guide to using Cell Counting Kit-8 in palmitate–albumin lipotoxicity studies, with practical controls for distinguishing true cell injury from formulation and metabolic artifacts.
-
Bafilomycin A1: From pH Biology to Translation
2026-08-09
A translational framework for using Bafilomycin A1 as a reversible V-ATPase inhibitor to distinguish lysosomal acidification, autophagy flux, and oxidative-stress responses, extending findings from sinapine-treated C2C12 myoblasts into broader cell biology, cancer research, and bone-resorption workflows.
-
5X Protein Loading Buffer (Reducing): SDS-PAGE Guide
2026-08-08
5X Protein Loading Buffer (Reducing) supports denaturing, reducing protein sample preparation before SDS-PAGE electrophoresis by combining SDS, a sulfhydryl reducing agent, tracking dye, and buffer salts. It is intended for molecular weight-based protein separation and should not be used when native protein structure or non-reducing conditions must be preserved.
-
Caspase-3, NDUFS1, and Trichothecene ROS
2026-08-07
This preprint identifies a mechanistic link between caspase-3 activation, cleavage of the mitochondrial complex I subunit NDUFS1, and ROS accumulation after DON or T-2 toxin exposure. It also implicates ER-localized ERO1α as a parallel ROS source, providing a framework for interpreting mitochondrial dysfunction and redox stress in toxin-exposed liver models.